ENLON Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Enlon, and what generic alternatives are available?
Enlon is a drug marketed by Pharmobedient and is included in three NDAs.
The generic ingredient in ENLON is atropine sulfate; edrophonium chloride. There are two drug master file entries for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ENLON?
- What are the global sales for ENLON?
- What is Average Wholesale Price for ENLON?
Summary for ENLON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 89 |
| DailyMed Link: | ENLON at DailyMed |
US Patents and Regulatory Information for ENLON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmobedient | ENLON | edrophonium chloride | INJECTABLE;INJECTION | 088873-001 | Aug 6, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019677-001 | Nov 6, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pharmobedient | ENLON-PLUS | atropine sulfate; edrophonium chloride | INJECTABLE;INJECTION | 019678-001 | Nov 6, 1991 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
